Cameron Warns Netflix–WBD Deal Could Threaten IMAX and Premium Theatres

Cameron’s warning raises alarms for IMAX and premium theatres

Consolidation Threatens Premium Exhibition

James Cameron is sounding the alarm over a possible Netflix acquisition of Warner Bros. Discovery, warning senators that the deal could imperil the theatrical business that companies such as IMAX rely on. In a letter to Sen. Mike Lee obtained by CNBC, Cameron calls the sale “disastrous for the theatrical motion picture business” and cautions that combining two of the largest streaming platforms risks reducing theatrical releases and jobs across Hollywood. That prospect directly threatens IMAX, whose large-format auditoriums depend on a steady stream of event films and studio-backed tentpoles to drive attendance and premium pricing.

Industry executives and exhibitors are watching Washington as lawmakers consider follow‑up antitrust scrutiny after early‑February hearings where Netflix co‑CEO Ted Sarandos and Warner Bros. Discovery executives testified. Cameron’s intervention escalates pressure on regulators who could block or condition a deal, a possibility that would materially affect distribution strategies that underpin IMAX’s revenue model. If consolidation prompts studios to prioritize direct-to-streaming premieres or shorter theatrical windows, IMAX faces lower utilisation of its premium screens and weaker leverage in negotiating presentation windows and revenue shares for major releases.

Netflix argues the opposite, pointing to testimony and a pledge to spend $20 billion on film and TV in 2026, a majority in the United States, and says a combined business will increase production investment. But exhibitors and filmmakers express scepticism that larger streaming conglomerates will sustain the cadence of global theatrical tentpoles or preserve the premium release patterns that fuel IMAX’s box-office performance. The dispute frames a key risk for IMAX: its growth strategy hinges on studios continuing to treat theatrical exhibition as the primary global launch platform for big‑budget, spectacle-driven films.

Analyst attention signals uncertainty

Analysts are rapidly reassessing IMAX amid these industry debates: nine distinct ratings arrive within three months, reflecting divergent views on the company’s prospects tied to content pipelines, theatre attendance recovery, and partnership dynamics. The flurry of opinions underscores that IMAX’s near‑term outlook is sensitive to how studios and regulators resolve questions around consolidation and distribution models.

Regulatory and industry stakes remain high

Lawmakers including Sen. Lee say they have received outreach from actors and directors and are considering further oversight, a development that could shape whether any deal proceeds and under what conditions. For IMAX and other premium exhibitors, regulatory outcomes and studios’ strategic choices over theatrical windows will be decisive for future revenues and the broader health of the theatrical ecosystem.